Inhibetex, Organic Soils.com Inc. deal

Cancer company Inhibetex reverse merged with OSLC in a stock deal. Inhibetex shareholders will own about 83% of the merged company, which will be named Inhibiton Therapeutics Inc. Inhibiton is studyin...